Introduction {#s1}
============

The search for bioactive metabolites including novel antibiotic compounds from microbial sources for potential use in agricultural, pharmaceutical, and industrial applications has become more important due to the development of drug/multi-drug resistance in most of the pathogenic microbes. Researchers across the globe are aggressively searching for new, potent, sustainable, and broad-spectrum antimicrobial compounds from various sources including microbes (Berdy, [@B5]; Hayakawa, [@B9]; Praveen et al., [@B25]; Singh and Tripathi, [@B29]). In natural soil habitat, *Streptomyces* are usually a major proportion of the total actinomycetes population and recognized as prolific producers of useful bioactive compounds (Tanaka and Omura, [@B32]; Kekuda et al., [@B15]).

Traditional screening methods have led to the isolation of common microorganisms capable of producing metabolites, which have already been extensively studied and established (Okami and Hotta, [@B22]; Kurtböke et al., [@B18]). Among the current strategies of natural-product screening, improved methodologies for isolating the uncommon and less studied rare actinomycetes are required to avoid the repeated isolation of the strains that produce known bioactive metabolites, and to improve the quality of the screened natural products (Takahashi and Omura, [@B31]; Berdy, [@B5]; Singh et al., [@B30]).

Likewise, the traditional methods of species classification and the identification of the organism(s) are mainly based on morphological, physiological, biochemical, developmental, and nutritional characters, and it is not adequate, and warrants for the use of molecular level approaches for assigning accurate taxonomic classification. Hence, precise assignment of taxonomic status to the novel bioactive microbial isolates through existing predictive bioinformatics methods and tools are very essential and aid in chemical characterization of the active molecules.

India has a unique asset of biodiversity, which can be used as a treasure for the search of novel isolates. With the variation of type of soil, according to the geographical changes, soil provide very complex habitat to the microbes residing in it. Due to this intricate environment, the soil microbes play an important role in the isolation of novel drugs. Among soil microbes, the members of *Streptomyces* sp. of actinomycetes, have been widely exploited for the production of commercially important secondary metabolites and enzymes. In the present study, the soil samples from six different unexplored agro-ecological niches of India have been screened-out to isolate *Streptomyces* sp. possessing antibacterial and antifungal activities.

Materials and methods {#s2}
=====================

Collection of soil samples
--------------------------

The soil samples were collected from six diverse habitats of India (Lucknow, Uttar Pradesh: 26.7°N, 80.9°E; Badrinath, Uttarakhand: 30.7440°N, 79.4930°E; Delhi, New Delhi: 28.6100°N, 77.2300°E; Bhatinda, Punjab: 30.2300° N, 74.9519° E; Haryana: 28.04°N 76.11°E; Thinmala range, Kerala: 8.5074°N, 76.9730°E) for the isolation of microbes. These habitats included rhizosphere of the plants, agricultural soil, hospital surroundings, river mud, and preserved areas of forest soils. The samples were collected from upto 20 cm depth after the removal of \~3.0 cm of the soil from the surface. The soil samples were collected in polyethylene bags, sealed, and stored in a refrigerator. All chemicals, media, media components, and other reagents were purchased from Sigma-Aldrich (USA), Merck (USA), HiMedia Laboratories (India) etc.

Pre-treatment of soil samples and isolation of cultures
-------------------------------------------------------

The soil samples collected from different geographical areas were pre-treated to eliminate the commonly found microbes using physico-chemical methods. For the physico-chemical treatment of the soil samples, one gram of each soil sample was suspended in 10 ml of normal saline and distributed in aliquots. One aliquot of the soil sample was treated with heat for 1 h at 120°C and the other was treated with 1.5% phenol for 30 min at 30°C as described by Hayakawa et al. ([@B10]). Afterwards, the physico-chemically treated soil samples were vortexed and left for 30 min, there after soil samples were serially diluted and 100 μl of each "dilution" was plated on nutrient agar (NA), actinomycetes isolation agar (AIA), yeast malt glucose agar (M6), antibiotic assay agar, starch casein agar, and Czapek Dox agar.

Screening of microbial cultures
-------------------------------

Primary screening for evaluating the antimicrobial potential of the axenic cultures was performed by perpendicular streak method of Madigan et al. ([@B19]) against the bacterial strains of *Bacillus subtilis* MTCC 441, *Staphylococcus aureus* MTCC 96, *Escherichia coli* MTCC 64, and *Candida albicans* MTCC 183. Isolates were screened for antagonism studies by inoculating a single streak of the pure producer organism in the middle of the assay media plate. The plates were incubated for 4 days at 28°C and subsequently seeded with "test" organism by a single streak at a 90° angle to the streak of the "producer strain" and finally the plates were incubated for 1--2 days at 28°C. The microbial interactions were analyzed by determining the distance of inhibition measured in mm.

Microbial strains showing "moderate" to "good" inhibition activity were selected for secondary screening, which was performed by agar well method (Wu, [@B34]), using 100 μl of their fermented broth against *B. subtilis* MTCC 441, *B. subtilis* MTCC 121, *B. pumilus* MTCC 1607, *S. aureus* MTCC 902, *S. aureus* MTCC 96, *E. coli* MTCC 1304, *Salmonella typhi* MTCC 734, *Pseudomonas aeruginosa* MTCC 741, *Proteus vulgaris* MTCC 426, *C. albicans* MTCC 3017, *C. albicans* MTCC 183, *C. tropicalis* MTCC 184, *Saccharomyces cerevisiae* MTCC 170, *Cryptococcus terreus* MTCC 1716, *Aspergillus niger* MTCC 1344, *Trichophyton rubrum* MTCC 296, *Penicillium chrysogenum* MTCC 2725, and *Beauveria bassiana* MTCC 4564. All the experiments were performed in triplicate and the average values were considered for analysis.

Characterization of microbial strain(s) from the selected cultures
------------------------------------------------------------------

The cultural characteristics of the producer strains were studied according to the method of Shirling and Gottlieb ([@B28]) based upon their intensity of growth, growth pattern, colony color along with the color of aerial and substrate mycelia, and the formation of soluble pigments on oat meal agar (ISP-3), inorganic salt starch agar (ISP-4), glycerol asparagine agar (ISP-5), peptone yeast extract iron agar (ISP6), and tyrosine agar (ISP-7). The strains were characterized by streaking the culture(s) on the above mentioned medium plates and observed after 7--10 days of incubation at 28°C for the given characteristics.

Physiological and biochemical tests were performed as described by Williams et al. ([@B33]) and Bergey\'s manual (Holt et al., [@B12]), and results were observed after 10 days of incubation of plates at 28°C. In addition, the strains were tested for nitrate reduction, tolerance to NaCl, decomposition of citrate, tartrate, acetate and pyruvate, and pH and temperature tolerance. The enzymatic activity assays of urease, amylase, protease and catalase were performed as suggested by Hopwood and Wright ([@B13]). Finally, on the basis of macroscopic, biochemical and physiological characteristics hierarchical cluster analysis was performed by using PASW Statistics (formerly SPSS Statistics) Version 18 software program and dendrogram was generated based on the average linkage between the groups.

Metabolite production
---------------------

Pure and active cultures of microbial strains selected from the secondary screening experiments were grown in X-medium (g/l: Soybean meal, 10; CaCO~3~, 3; MgSO~4~.7H~2~O, 0.5; (NH~4~)~2~HPO~4~, 0.5; NaCl, 3; K~2~HPO~4~, 1; glycerol, 15 ml; DW 1, pH 6.9--7.0), and incubated at 28°C for 3--5 days and cellular growth was confirmed by visible pellets, clumps, aggregates or turbidity in the culture broth. The culture broths were centrifuged separately and filtrates were used to evaluate the antimicrobial activity against the above mentioned test microorganisms. Antibiotic activities of the strains were compared with that of known commercially available erythromycin (E^15^) and amphotericin B (AmB^100^).

Extraction, purification, and partial characterization of the active compounds
------------------------------------------------------------------------------

Fermented culture was centrifuged at 10,000 rpm for 20 min to separate the biomass. The active metabolite was recovered from the fermented broth using two phase solvent extraction system with organic solvent. Solvents containing the active compounds were concentrated under vacuum to get "dried crude." The obtained "crude" was treated with non-polar solvents like hexane or chloroform to separate the polar and non-polar components. The active components were purified by adsorption chromatography using silica gel (pore size 60 Å, mesh size: 230--400, particle size 40--63 μm) as a stationary phase and gel filtration chromatography using sephadex LH-20. The eluted fractions were assayed for their bioactivity against *B. subtilis* ATCC 6633 and *C. albicans* ATCC 24433 by disc diffusion method (Wu, [@B34]). The purity of the active fractions was further checked by high pressure liquid chromatography (HPLC) using reverse phase silica column (RP18). Finally, the UV spectra (Perkin Elmer Lambda-25 UV spectrophotometer) of various antibacterial and antifungal compounds were determined in methanol at 200--500 nm wave length.

Results {#s3}
=======

Screening of the active strains
-------------------------------

During the screening, thirty six actinomycetes were isolated from six different stressed agro-ecological niches of India. Microbial colonies showing distinct morphological characters were selected for the primary screening (Figure [1](#F1){ref-type="fig"}). Out of 36 total actinomycetes isolates, 15 showed moderate to strong antimicrobial activity against gram positive (*B. subtilis* MTCC6633, *S. aureus* MTCC 6538), gram negative (*E. coli* MTCC 1304) and fungal strain (*C. albicans* MTCC 1346). The active strains (actinomycetes) were further subjected to the secondary screening against some multi-drug resistant (MDR) bacterial as well as fungal test strains (Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}). The screening results suggested that most of the isolates were active against gram positive bacteria in comparison with gram negative bacteria (Figures [2A,B](#F2){ref-type="fig"}). Out of 15 active isolates, 13 showed strong antimicrobial activity and were selected for detailed taxonomic, physiological, and biochemical studies.

![**Primary screening using perpendicular streak method for antibacterial and antifungal activity of the soil isolate (ZA25)**.](fmicb-07-01921-g0001){#F1}

###### 

**Secondary screening (antibacterial activity)**.

  **Sr. No**   **Test strains**                    **Soil isolates (zone of Inhibition in mm)**   **PC**                                                                    
  ------------ ----------------------------------- ---------------------------------------------- -------- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----
  1            *Bacillus subtilis* MTCC 441        16                                             16       13   27   22   23   21   --   --   20   17   25   12   13   11   30
  2            *Bacillus subtilis* MTCC 121        16                                             16       --   17   16   19   19   --   --   17   16   25   --   12   --   30
  3            *Bacillus pumilus* MTCC 1607        21                                             21       18   25   21   26   15   13   --   --   17   30   --   --   --   --
  4            *Staphylococcus aureus* MTCC 96     23                                             17       --   20   17   25   24   --   24   24   20   21   --   13   11   25
  5            *Staphylococcus aureus*, MTCC 902   --                                             --       --   14   17   --   --   12   25   20   15   30   --   14   11   17
  6            *Escherichia coli* MTCC 1304        --                                             --       --   --   12   16   --   --   --   19   17   --   --   --   --   20
  7            *Pseudomonas aeruginosa* MTCC 741   --                                             --       13   27   15   18   27   --   20   20   15   28        --   --   37
  8            *Proteus vulgaris* MTCC 426         16                                             16       --   15   18   --   --   14   --   14   18   30   --   12   --   12
  9            *Salmonella typhi* MTCC 581         --                                             --       --   15   15   18   17   12   --   16   16   29   --   --   --   13
  10           *Klebsiella pneumonia* MTCC 13883   15                                             14       --   16   17   18   --   12   23   17   15   25   --   --   --   --

*(−), not active; PC, Positive Control; E^15^, Erythromycin and well diameter = 10 mm*.

###### 

**Secondary screening (antifungal activity)**.

  **Sr. No**   **Test strains**                      **Soil isolates (zone of inhibition in mm)**   **PC**                                                                    
  ------------ ------------------------------------- ---------------------------------------------- -------- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----
  1\.          *Candida albicans* MTCC 183           16                                             15       --   --   --   --   --   11   12   --   12   --   12   --   --   25
  2\.          *Candida albicans* MTCC 3017          30                                             30       15   14   --   27   19   18   11   --   18   --   --   --   --   25
  3\.          *Candida tropicalis* MTCC 184         14                                             11       --   --   --   13   --   18   --   --   21   --   --   --   --   20
  4\.          *Cryptococcus terreus* MTCC 1716      25                                             25       --   --   --   19   --   15   --   --   16   --   --   --   --   12
  5\.          *Saccharomyces cerevisiae* MTCC 170   21                                             23       --   --   --   25   28   20   --   --   23   --   11   11   --   20
  6\.          *Kluyveromyces lactis* MTCC32         27                                             24       --   --   21   21   31   20   --   --   29   --   13   13   --   12
  8\.          *Penicillium chrysogenum* MTCC 2725   19                                             11       --   --   --   --   --   --   --   --   20   --   --   --   13   --
  9\.          *Aspergillus niger* MTCC 1344         --                                             12       12   --   --   12   13   --   --   --   14   --   --   --   15   --
  11\.         *Trichophyton rubrum* MTCC 296        --                                             --       --   --   18   16   14   12   --   --   20   --   --   13   12   32
  12\.         *Beauveria bassiana* MTCC 4564        16                                             20       20   11   --   --   19   --   --   --   --   --   --   --   --   --

*(−), not active; PC, positive control; AmB, Amphotericin B and well diameter = 10 mm*.

![**(A)** Secondary screening of the soil isolates for the antibacterial activities. **(B)** Secondary screening of the soil isolates for the antifungal activities.](fmicb-07-01921-g0002){#F2}

Characterization of the strains
-------------------------------

The cultural characteristics, such as microbial growth along with its pattern and pigment formation were studied on International *Streptomyces* Project (ISP) media and their results are summarized in Table [3](#T3){ref-type="table"}. All the selected actinomycetes isolates showed moderate to heavy growth on nitrate agar, urease agar and inorganic salt starch agar medium, which suggests their capability of breaking down the above complexes. Heavy growth and color change (from green to blue) of Simmons\' Citrate Agar (SCA) medium provide the evidence of citrate utilizing ability of the actinomycetes strains YE21, YE22, and YE23. Likewise, melanin formation was demonstrated by the presence of brown to black patches on inorganic salt starch agar (ISP4) and YMG (yeast extract 4 g, malt extract 10 g, glucose 4 g, agar 20 g, water 1 L) medium as a result of the growth of the active strains. This was observed in almost all the selected strains.

###### 

**Cultural and Biochemical characteristics of the producer strains**.

                                   **Producer strains**                                                          
  ------------------- ------------ ---------------------- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----
  Growth on           ISP2         2+                     \+   2+   2+   2+   \+   2+   3+   3+   2+   3+   --   3+
                      ISP3         2+                     \+   2+   2+   2+   2+   2+   2+   3+   3+   --   2+   2+
                      ISP4         3+                     2+   2+   3+   3+   2+   3+   \+   2+   3+   --   3+   3+
                      ISP5         2+                     2+   \+   2+   \+   \+   2+   \+   \+   2+   --   2+   2+
                      ISP6         3+                     2+   2+   3+   2+   \+   \+   \+   2+   2+   \+   \+   2+
                      ISP7         \+                     2+   \+   \+   \+   \+   3+   2+   3+   2+   \+   --   \+
  Utilization of      Citrate      --                     --   --   \+   \+   --   --   2+   2+   2+   --   --   --
                      Asparagine   3+                     2+   \+   --   2+   --   --   \+   \+   \+   \+   --   --
                      Oat meal     2+                     \+   2+   --   2+   2+   2+   2+   3+   3+   --   2+   2+
                      Tributyrin   2+                     2+   2+   2+   3+   \+   --   --   --   \+   --   \+   \+
  Enzyme production   Urease       --                     --   −    −    −    \+   −    2+   −    \+   −    −    \+
                      Amylase      3+                     2+   2+   2+   3+   2+   3+   \+   2+   3+   −    3+   3+
                      Tyrosinase   3+                     2+   −    \+   \+   \+   3+   2+   3+   2+   \+   −    \+
                      Chitinase    3+                     2+   2+   2+   \+   −    −    3+   \+   \+   −    −    \+
                      Heparinase   −                      −    −    −    3+   −    −    −    −    −    −    −    −
                      Protease     2+                     2+   2+   2+   2+   \+   2+   3+   3+   2+   3+   \+   3+
                      Catalase     2+                     2+   2+   2+   2+   \+   \+   2+   2+   3+   2+   \+   \+
  pH tolerance        5            3+                     3+   2+   3+   3+   3+   3+   3+   3+   2+   2+   2+   3+
                      7            3+                     2+   3+   3+   3+   \+   2+   3+   3+   3+   \+   \+   3+
                      9            2+                     3+   \+   3+   3+   \+   \+   3+   3+   2+   2+   \+   3+
                      11           −                      2+   \+   2+   3+   \+   \+   3+   3+   2+   \+   \+   2+
  NaCl tolerance      1%           3+                     3+   3+   3+   3+   \+   3+   3+   3+   2+   2+   \+   3+
                      3%           \+                     2+   2+   3+   3+   −    \+   3+   3+   3+   −    \+   \+
                      5%           −                      −    \+   2+   2+   −    −    3+   3+   2+   −    −    \+
                      7%           −                      −    \+   \+   \+   −    −    \+   3+   \+   −    −    −
  Growth at           28°C         3+                     2+   3+   3+   2+   \+   2+   3+   \+   3+   \+   \+   3+
                      37°C         3+                     3+   2+   3+   3+   2+   2+   3+   \+   3+   \+   −    3+
                      47°C         −                      −    −    −    \+   −    −    −    −    −    −    −    −

*(−), No growth; (+1), Poor growth; (+2), Moderate growth; (+3), Heavy growth*.

All the strains were capable of reducing nitrate salts but they demonstrated some differences against the decomposition of starch and urea. The production of amylase, urease and protease enzymes by the actinomycetes strains was endorsed by their growth on ISP4, urease agar and ISP3 mediums. Except the actinomycetes strains ZA25, ZA26, and YE22, the most favorable temperature range for the growth of strains was 27--37°C. Interestingly, none of the selected strains were able to grow at 50°C or above. All the selected actinomycetes strains possessed the ability to tolerate 3% NaCl in the medium with the exception of strains ZE18 and ZA25.

Hierarchical cluster analysis
-----------------------------

Strains found to be active in primary and secondary screening were subjected to hierarchical cluster analysis based on 49 macroscopic, biochemical and physiological characters. The dendrograms based on the average linkage between the groups were generated by PASW Statistics (formerly SPSS Statistics) Version 18 software. Two broad clusters were generated (Figure [3](#F3){ref-type="fig"}). The first cluster contained four (ZE18, ZE19, ZA25, and ZA26) and the second cluster contained nine actinomycetes (YE23, RS25, H1, V1, N1, S1, YE22, YE21, and K1) isolates. The first cluster was further divided into two sub cluster sub-clad 1.1 and 1.2. The sub-clad 1.1 leaded ZA25 alone whereas sub-clad 1.2 further divided into 1.2.1 and 1.2.2 and so on, and ultimately formed a branched group of three isolates (ZE18, ZE19, and ZA26). Similarly, the second cluster was divided into sub-clad 2.1 and 2.2. The sub-clad 2.1 was further divided into 2.1.1 and 2.1.2 (YE21 and YE2,), whereas sub-clad 2.2 was further divided into 2.2.1 and 2.2.2 and so on, and ultimately formed a branched group of seven isolates (YE23, RS25, H1, V1, N1, S1, and K1).

![**Phylogenetic tree showing evolutionary relationship of the soil isolates**.](fmicb-07-01921-g0003){#F3}

Based upon the potential antimicrobial activities shown in the primary and secondary screenings, five out of thirteen strains were finally selected for further characterization using 16S rRNA homology studies. The generated dendrogram showed that all the five strains (H1, V1, S1, RS25, and ZA25) were evolutionary far away from each other and displayed varying biochemical characteristics along with excellent antimicrobial activity. The diversity was maintained when we compared the antimicrobial activity data and the UV spectra of the metabolites. Strains, ZA25 and H1 belong to the main cluster I and II, respectively, found to produce both antibacterial and antifungal compounds having different UV absorbance. Similarly, H1, V1, and S1 produce antibacterial compounds and belong to the same cluster II; but their sub-clad were different. Variations in the UV absorbance of the metabolites supported the positional difference of the strains in the dendrogram. The 16S rRNA study for the strains H1, V1, and S1 were performed at Microbial Type Culture Collection (MTCC), Chandigarh, Punjab (India), and identified and submitted to MTCC as - *Streptomyces xanthophaeus* MTCC 11938, *Streptomyces variabilis* MTCC 12266, and *Streptomyces xanthochromogenes* MTCC 11937, respectively. Whereas, the 16S rRNA homology sequence study for the strain RS25 and ZA25 was done at Genomebio Technologies Pvt. Ltd., Pune, Maharashtra (India) and identified and submitted to National Collection of Industrial Microorganisms (NCIM), CSIR-NCL, Pune, Maharashtra (India) as *Streptomyces levis* EU 124569 and *Streptomyces* sp. NCIM 5500, respectively.

Partial chemical characterization of the active compounds
---------------------------------------------------------

The bioactive compounds were purified from the selected actinomycetes strains using silica column, with methanol:chloroform gradient as an eluting solvent system. The purified fractions were partially characterized by observing under UV absorbance (λ~max~) and their absorption pattern to gather some preliminary information regarding the structure of the compound(s) (Table [4](#T4){ref-type="table"}). Absorbance within UV range confirmed the presence of "*unsaturation*" in all the bioactive compounds. All the active metabolites except from the strain RS25 contained either carboxyl or peptide moiety in their structure. Absorbance band near 253 nm indicated the presence of benzene moiety in H1F2 (antifungal; AF), H1F1 (antibacterial; AB) and ZA25 AF strains. Among antifungal compounds, absence of conjugated absorption suggested non-polyene nature of H1F1 and ZA25 AF. The presence of carboxyl or peptide moieties was further confirmed by IR spectra of the compounds. Hydroxyl and conjugated carbonyl functional moiety in the compound were confirmed by the presence of absorption bands at 3425 and 1648 cm^−1^, respectively. The absorption bands detected at 3020 and 2927 cm^−1^ correspond to aromatic C-H and alkyl C-H stretching, respectively, and suggested the presence of aromatic ring in the antibacterial compound isolated from ZA25 and absence in the compound isolated from V1. Further, presence of aromatic ring was verified by the absorption bands at 1602 and 1504 cm^−1^ attributed to C = C ring stretching.

###### 

**IR spectra of bioactive compounds isolated from the selected actinomycetes strains**.

  **Strains**   **Identification**                 **Nature of purified compound**   **UV absorbance**   **IR frequency**
  ------------- ---------------------------------- --------------------------------- ------------------- ----------------------------------------------------------------------
  H1F1          *Streptomyces xanthophaeus*        Antibacterial                     201, 260            3409, 3019, 2400, 1658, 1402, 1384, 1215, 1053, 948, 758, 668
  ZA25F1        *Streptomyces* sp.                 Antibacterial                     264, 495            3411, 3019, 2400, 1647, 1403, 1070, 928, 669
  V1            *Streptomyces variabilis*          Antibacterial                     210                 3412, 2928, 1646, 1215, 1070,
  RS25          *Streptomyces levis*               Antibacterial                     240-250 and 332     3425 and 1648, 3020 and 2927, 1602 and 1504 cm^−1^
  S1            *Streptomyces xanthochromogenes*   Antifungal                        205, 490            3411, 3020, 1646, 1403, 1385, 1216, 1069, 769
  H1F2          *Streptomyces xanthophaeus*        Antifungal                        201, 265            3850, 3431, 3020, 2399, 2110, 1637, 1403, 1385, 1017, 669
  ZA25F2        *Streptomyces* sp.                 Antifungal                        205, 248, 263,      3850, 3366, 2945, 2833, 2518, 2042, 1638, 1449, 1218, 1113, 757, 666

Discussion {#s4}
==========

During the screening of rare actinomycetes, fast growing bacterial colonies inhibits the colonization of actinomycetes on the isolation medium, hence in order to isolate actinomycetes, the growth of these bacteria should be inhibited. Pre-treatment of the soil samples reduced the growth of ubiquitous microbial species, thereby facilitated the recovery of less-abundant microorganisms. The spores of actinomycetes and fungi generally resist desiccation and show slightly higher resistance toward wet or dry heat than other microbes (Hopwood and Wright, [@B13]). Pre-treatment of the soil suspension with 1.5% phenol (30°C for 30 min) lowered the number of bacteria, fungi, and other common actinomycetes by denaturing their proteins or by disrupting their cell membrane, however phenol-resistant actinomycetes were less affected during this process (Hayakawa et al., [@B10]). Earlier, Hayakawa et al. ([@B10]) and Kim et al. ([@B16]) reported the use of above mentioned pre-treatment of the soil samples for the isolation of actinomycetes, and they reported similar results, when the soil samples were pre-treated.

A total of 15 isolated strains were subjected to antimicrobial screening and it was found that most of the isolates were active against gram positive bacteria. This was majorly attributed to the presence of lipopolysaccharide (LPS), a major structural unit of gram negative bacterial cell wall. LPS is hydrophobic in nature and makes the cell wall impermeable to lipophilic solutes, whereas in absence of LPS in the cell wall of gram positive bacteria, they become susceptible to the metabolites (Kim et al., [@B17]).

Out of 15 strains, thirteen showed strong antimicrobial activity and were selected for detailed microbial characterization studies. Melanin formation was also observed in almost all the selected strains, which is a main diagnostic feature of *Streptomyces* sp. (Singh et al., [@B30]). Further, five strains were characterized by using nucleotide sequencing and designated as H1: *S*. *xanthophaeus* MTCC 11938, V1: *S*. *variabilis* MTCC 12266, S1: *S*. *xanthochromogenes* MTCC 11937, RS25: *S*. *levis* EU124569, and ZA 25: *Streptomyces* sp. NCIM 5500. Evolutionary distance of the above five strains (H1, V1, S1, RS25, and ZA 25) was also analyzed by measuring their positions in the dendrogram. Based upon the diversity achieved by the morphological, biochemical, and the phylogenetic characteristics in the selected strains, we can speculate the possibility of involvement/role of diverse bioactive compounds from these strains, responsible for their broad-spectrum antimicrobial properties.

During the purification of the metabolites from ultra violet spectra, maximum absorbance between 205 and 216 nm suggested the presence of carboxyl or peptide moiety in the structure of all the active metabolites except from the strain RS25 (Singh et al., [@B30]; Kang et al., [@B14]). However, absorbance at 240--250 and at 332 nm predicted the presence of chromone like nucleus in strain RS25 (Griffiths and Ellis, [@B8]).

Pertinent literature about the producer strains were searched using SciFinder software program and it was found that *S. xanthophaeus* is known to produce diverse array of metabolites including Postproline endopeptidase, Benarthin, β-galactosidase-inhibiting isoflavonoids and geomycins (Brockmann and Musso, [@B6]; Hazato et al., [@B11]; Aoyagi et al., [@B3]; Shibamoto et al., [@B27]). *S*. *xanthochromogenes* are also known to produce diverse array of chemical compounds such as Diastereoisomeric I-Na, Nitropeptin, xanthicin (I), Pravastatin, reductiomycin, alkaloid AM-6201 (Arishima et al., [@B4]; Onda et al., [@B23]; Ohba et al., [@B21]; Otake et al., [@B24]; Cho et al., [@B7]; Zhang et al., [@B35]). Eleven compounds having same molecular formula have been reported from *S. levis*. Those were oleandomycin, 2-piperidinone and derivatives of either erythromycin or tylonolide. *S. variabilis* is reported for the production of L-Glutaminase, imunosuppresive, clavulanic acid, glycoside antibiotic and 1-hydroxy-1-norresistomycin (Abd-Alla et al., [@B1], [@B2]; Marques et al., [@B20]; Ramalingam and Rajaram, [@B26]).

To the best of our knowledge, this is very first time we are reporting the antifungal activity of *S. xanthophaeus* and *S*. *xanthochromogenes*. Similarly, the compounds reported from *S. levis* didn\'t show the presence of chromone like structure. Also, the antifungal compound purified from *S*. *xanthochromogenes* was confirmed as chitinase by performing enzyme assay.

In conclusion, the results of morphological and biochemical characterization and the nature of compounds produced by the microbes established the diversity among the member of actinomycetes. The antimicrobial activities achieved in this study indicate that the isolated strains of *Streptomyces* sp. from different geographical niches of India have potential to produce diverse array of antimicrobial compounds that can be useful for many great applications and must be explored extensively. Currently, our research group and collaborators are actively involved in the chemical characterization of the active compounds identified in this study. In addition, *in silico* predictive studies for target prediction are under progress with our collaborator group. Hopefully, in our successive publication we would be reporting the complete information regarding the chemical characteristics of the "*actives*" identified in this study and their targets predicted through *in silico* binding studies and their experimental validation.
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